KIMS vs RAINBOW: Stock Comparison

KRISHNA INST OF MED SCI L vs RAINBOW CHILDRENS MEDUpdated 18 Sept 26, 4:08 PM ISTNSE & company filings

KRISHNA INST OF MED SCI L is the larger company by market capitalisation. KRISHNA INST OF MED SCI L shows faster revenue growth, while RAINBOW CHILDRENS MED shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

KIMS leads 2; RAINBOW leads 11 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

KIMSRAINBOW

Valuation lens

What price are you paying?

Market CapContext only
₹34,021 Cr
₹14,702 Cr
P/E RatioRAINBOW has the lower reading
160.08x
51.52x
P/B RatioRAINBOW has the lower reading
14.42x
8.92x
EPSRAINBOW has the higher reading
₹0.99
₹5.19
Book ValueContext only
₹60.92
₹163.8
Dividend YieldRAINBOW has the higher reading
0%
0.24%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
KIMS is the larger company
₹34,021 Cr vs ₹14,702 Cr
P/E Ratio
RAINBOW has a lower P/E
51.52x vs 160.08x
P/B Ratio
RAINBOW has a lower P/B
8.92x vs 14.42x
EPS
RAINBOW has higher earnings per share
₹5.19 vs ₹0.99
Dividend Yield
RAINBOW has a higher dividend yield
0.24% vs 0%
Revenue Growth (TTM YoY)
KIMS has faster revenue growth
34.8% vs 24.3%
EPS Growth (TTM YoY)
RAINBOW has faster EPS growth
39.1% vs -58.3%
Qtr Sales Growth
KIMS has stronger quarterly sales growth
143.9% vs -12.65%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricKIMSRAINBOW
SectorHealthcareHealthcare
IndustryHospitalHospital

Price

MetricKIMSRAINBOW
Live Price₹809.85₹1,454.7
Day Change2.27%-1.27%
Volume12.42 L99,805
52-Week High₹858₹1,610
52-Week Low₹575.8₹1,084
Distance from 52W High-5.61%-9.65%

Valuation

MetricKIMSRAINBOW
Market Cap₹34,021 Cr₹14,702 Cr
P/E Ratio160.08x51.52x
P/B Ratio14.42x8.92x
EPS₹0.99₹5.19
Book Value₹60.92₹163.8
Dividend Yield0%0.24%

Growth

MetricKIMSRAINBOW
Revenue Growth (TTM YoY)34.8%24.3%
EPS Growth (TTM YoY)-58.3%39.1%
Qtr Sales Growth143.9%-12.65%
Qtr Profit Growth-43.76%-15.72%

Profitability & Leverage

MetricKIMSRAINBOW
ROE10.73%14.8%
ROCE8.27%18.17%
Net Margin6.18%16.34%
Operating Margin25.35%26.24%
Debt to Equity0.6x0.01x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricKIMSRAINBOW
Promoter Holding32.5% 1.61 pp49.84%
FII Holding14.74% 0.17 pp16.03% 1.21 pp
DII Holding34.43% 1.93 pp22.56% 1.43 pp
Public Holding18.33% 0.49 pp11.39% 0.28 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: KRISHNA INST OF MED SCI L and RAINBOW CHILDRENS MED.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.